Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Theravance presents in vivo results on its new SSRI candidate

May 4, 2012

Genentech ADC shows potential in prostate cancer models

May 4, 2012

Results disclosed from ENABLE trials

May 4, 2012

Ammonia scavenger assessed in healthy volunteers and patients with cirrhosis

May 4, 2012

Study in Chinese children links LINE-1 methylation to congenital heart defect

May 3, 2012

Second-generation cyclophilin inhibitor selected for clinical development in hepatitis C

May 3, 2012

Multikinase inhibitor from Piramal Life Sciences significantly suppresses tumor growth

May 3, 2012

New phase III results reported on Biogen Idec drug for MS

May 3, 2012

Liposomal GAP-107B8 has promising pharmacokinetics in rats

May 2, 2012

Mecasermin shows promise in Rett's syndrome

May 2, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...